phosphoenolpyruvate has been researched along with Anemia, Congenital Nonspherocytic Hemolytic in 10 studies
Phosphoenolpyruvate: A monocarboxylic acid anion derived from selective deprotonation of the carboxy group of phosphoenolpyruvic acid. It is a metabolic intermediate in GLYCOLYSIS; GLUCONEOGENESIS; and other pathways.
phosphoenolpyruvate : A monocarboxylic acid anion resuting from selective deprotonation of the carboxy group of phosphoenolpyruvic acid.
phosphoenolpyruvic acid : A monocarboxylic acid that is acrylic acid substituted by a phosphonooxy group at position 2. It is a metabolic intermediate in pathways like glycolysis and gluconeogenesis.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Phosphoenolpyruvate was better than adenosine-5'-diphosphate for protection against bromopyruvate modification whereas fructose-1,6-diphosphate was ineffective." | 1.31 | Modification of human erythrocyte pyruvate kinase by an active site-directed reagent: bromopyruvate. ( Acan, NL; Ozer, N, 2001) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (70.00) | 18.7374 |
| 1990's | 1 (10.00) | 18.2507 |
| 2000's | 2 (20.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Smith, O | 1 |
| Temperley, IJ | 1 |
| Tipton, K | 1 |
| McCann, SR | 1 |
| Lakomek, M | 2 |
| Schröter, W | 2 |
| Winkler, H | 2 |
| Elder, GE | 1 |
| Lappin, TR | 1 |
| Lawson, BE | 1 |
| Bridges, JM | 1 |
| Wang, C | 1 |
| Chiarelli, LR | 1 |
| Bianchi, P | 1 |
| Abraham, DJ | 1 |
| Galizzi, A | 1 |
| Mattevi, A | 1 |
| Zanella, A | 1 |
| Valentini, G | 1 |
| Acan, NL | 1 |
| Ozer, N | 1 |
| Gherardi, M | 1 |
| Bierme, R | 1 |
| Corberand, J | 1 |
| Vergnes, H | 1 |
| Boivin, P | 2 |
| Galand, C | 2 |
| Nakashima, K | 1 |
| Miwa, S | 1 |
| Fujii, H | 1 |
| Shinohara, K | 1 |
| Yamauchi, K | 1 |
| Tsuji, Y | 1 |
| Yanai, M | 1 |
| Neubauer, B | 1 |
| von der Lühe, A | 1 |
| Hoch, G | 1 |
10 other studies available for phosphoenolpyruvate and Anemia, Congenital Nonspherocytic Hemolytic
| Article | Year |
|---|---|
A pyruvate kinase variant with an increased affinity for phosphoenolpyruvate in an individual with congenital non-spherocytic haemolytic anaemia.
Topics: Adenosine Triphosphate; Anemia, Hemolytic, Congenital; Anemia, Hemolytic, Congenital Nonspherocytic; | 1983 |
Red cell pyruvate kinase deficiency: an optimised assay.
Topics: Adenosine Diphosphate; Anemia, Hemolytic, Congenital Nonspherocytic; Erythrocytes; Fructosediphospha | 1980 |
Three pyruvate kinase variants with increased affinity for PEP.
Topics: Adenosine Triphosphate; Adult; Anemia, Hemolytic, Congenital Nonspherocytic; Child; Diphosphoglyceri | 1981 |
Human erythrocyte pyruvate kinase: characterization of the recombinant enzyme and a mutant form (R510Q) causing nonspherocytic hemolytic anemia.
Topics: Adenosine Triphosphate; Amino Acid Sequence; Amino Acid Substitution; Anemia, Hemolytic, Congenital | 2001 |
Modification of human erythrocyte pyruvate kinase by an active site-directed reagent: bromopyruvate.
Topics: Adenosine Diphosphate; Anemia, Hemolytic, Congenital Nonspherocytic; Binding Sites; Enzyme Inhibitor | 2001 |
Heterogeneity of erythrocyte pyruvate kinase deficiency and related metabolic disorders in patients with hematological diseases.
Topics: Adenine Nucleotides; Adenosine Triphosphate; Anemia, Hemolytic, Congenital Nonspherocytic; Diphospho | 1977 |
[Significance of kinetic abnormalities of erythrocyte pyruvate kinase in congenital deficiencies].
Topics: Adenosine Triphosphate; Anemia, Hemolytic, Congenital Nonspherocytic; Erythrocytes; Fructosephosphat | 1977 |
Characterization of pyruvate kinase from the liver of a patient with aberrant erythrocyte pyruvate kinase, PK Nagasaki.
Topics: Adolescent; Adult; Anemia, Hemolytic, Congenital Nonspherocytic; Electrophoresis, Polyacrylamide Gel | 1977 |
Erythrocyte pyruvate kinase deficiency: relations of residual enzyme activity, altered regulation of defective enzymes and concentrations of high-energy phosphates with the severity of clinical manifestation.
Topics: 2,3-Diphosphoglycerate; Adenosine Diphosphate; Adenosine Triphosphate; Anemia, Hemolytic, Congenital | 1992 |
A mutant of human red cell pyruvate kinase with high affinity for phosphoenolpyruvate.
Topics: Adenosine Diphosphate; Adenosine Triphosphate; Adult; Anemia, Hemolytic, Congenital Nonspherocytic; | 1974 |